株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

体外毒性検査の世界市場 - 2024年までの予測:発がん性検査、経皮毒性検査

In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays), Industry, Region - Global Forecast to 2024

発行 MarketsandMarkets 商品コード 298990
出版日 ページ情報 英文 254 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.54円で換算しております。
体外毒性検査の世界市場 - 2024年までの予測:発がん性検査、経皮毒性検査 In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays), Industry, Region - Global Forecast to 2024
出版日: 2019年09月25日 ページ情報: 英文 254 Pages
概要

体外毒性検査市場は、2019年の81億米ドルから、2024年までに127億米ドルまで拡大すると見られています。市場は、2019年~2024年のCAGR (複合年間成長率) で、9.3%の成長が予測されています。

当レポートでは、世界の体外毒性検査市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

298990_4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW_FIGURE 13

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 体外毒性検査市場の概要
  • アジア太平洋地域 - 体外毒性検査市場:手法別
  • 体外毒性検査市場:地域別の成長機会
  • 体外毒性検査市場:地域別
  • 体外毒性検査市場:先進市場 vs. 途上市場

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 産業考察

  • イントロダクション
  • 産業動向
  • サプライチェーン分析
  • 規制委員会の活動

第7章 体外毒性検査の世界市場:製品・サービス別

  • イントロダクション
  • 消耗品
  • アッセイ
  • 装置
  • ソフトウェア
  • サービス

第8章 体外毒性検査の世界市場:毒性エンドポイント・検査別

  • イントロダクション
  • ADME (吸収、分布、代謝、排泄)
  • 皮膚刺激性、腐食性、感作性
  • 遺伝毒性
  • 細胞毒性
  • 眼毒性
  • 臓器毒性
  • 光毒性
  • 経皮毒性
  • その他

第9章 体外毒性検査の世界市場:技術別

  • イントロダクション
  • 細胞培養技術
  • ハイスループット技術
  • トキシコゲノミクス (毒性ゲノム学)

第10章 体外毒性検査の世界市場:産業別

  • イントロダクション
  • 製薬・バイオ医薬品
  • 化粧品・家庭用品
  • 食品
  • 化学

第11章 体外毒性検査の世界市場:手法別

  • イントロダクション
  • セルベースアッセイ
  • バイオケミカルアッセイ
  • in silicoモデル
  • ex vivoモデル

第12章 体外毒性検査の世界市場:地域別

  • イントロダクション
  • 欧州
  • 北米
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第13章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合リーダーシップマッピング
  • 競合状況・動向

第14章 企業プロファイル

  • THERMO FISHER SCIENTIFIC, INC.
  • MERCK KGAA
  • EUROFINS SCIENTIFIC SE
  • GE HEALTHCARE
  • COVANCE, INC.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • SGS S.A.
  • BIO-RAD LABORATORIES, INC.
  • QIAGEN N.V.
  • CYPROTEX PLC
  • PROMEGA CORPORATION
  • CATALENT, INC.
  • GENTRONIX LIMITED
  • MB RESEARCH LABORATORIES
  • BIOIVT
  • CREATIVE BIOLABS
  • GVK BIOSCIENCES PRIVATE LIMITED
  • SHANGHAI MEDICILON INC.
  • CREATIVE BIOARRAY
  • INSPHERO

第15章 付録

図表

LIST OF TABLES

  • TABLE 1: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 2: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 3: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 4: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 5: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 6: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 7: CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 9: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 10: OTHER ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 11: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 12: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 13: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 14: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 15: ADME TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 16: SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 19: OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 20: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21: PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22: DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 23: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 24: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 25: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 26: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 28: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 29: PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 30: COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31: TYPES OF TOXICOLOGICAL TESTS IN THE FOOD INDUSTRY
  • TABLE 32: FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 33: CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 35: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 36: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 37: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 40: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 41: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 42: EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 43: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 44: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 45: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 46: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 47: GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 48: GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 49: GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 50: GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 51: GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 52: GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 53: UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 54: UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55: UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 56: UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 57: UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 58: UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 59: FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 60: FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 61: FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 62: FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 63: FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 64: FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 65: ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 66: ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 67: ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 68: ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 69: ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 70: ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 71: SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 72: SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 73: SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 74: SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 75: SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 76: SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 77: ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 78: ROE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 79: ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 80: ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 81: ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 82: ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 83: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 84: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 85: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 86: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 87: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 88: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 89: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 90: US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 91: US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 92: US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 93: US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 94: US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 95: US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 96: CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 97: CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 99: CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 100: CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 101: CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 102: ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 103: ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 104: ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 105: ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 106: ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 107: ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 108: ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 109: CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 110: CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 111: CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 112: CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 113: CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 114: CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 115: JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 116: JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 117: JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 118: JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 119: JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 120: JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 121: INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 122: INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 123: INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 124: INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 125: INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 126: INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 127: ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 128: ROAPAC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 129: ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 130: ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 131: ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 132: ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 133: LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 134: LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 135: LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 136: LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 137: LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 138: LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 139: MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 140: MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 141: MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2024 (USD MILLION)
  • TABLE 142: MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 143: MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2024 (USD MILLION)
  • TABLE 144: MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 145: PRODUCT & SERVICE LAUNCHES, 2017-2019
  • TABLE 146: EXPANSIONS, 2017-2019
  • TABLE 147: ACQUISITIONS, 2017-2019
  • TABLE 148: OTHER STRATEGIES, 2017-2019

LIST OF FIGURES

  • FIGURE 1: IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE APPROACH
  • FIGURE 5: BOTTOM-UP APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019 VS. 2024 (USD MILLION)
  • FIGURE 12: GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 13: OPPOSITION TO ANIMAL TESTING IS A MAJOR FACTOR DRIVING MARKET GROWTH
  • FIGURE 14: CELLULAR ASSAYS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC IN VITRO TOXICOLOGY TESTING MARKET IN 2018
  • FIGURE 15: CHINA SHOWS THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: EUROPE WILL CONTINUE TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET IN 2024
  • FIGURE 17: DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 18: IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 20: CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: ORGAN TOXICITY TESTING TO REGISTER THE HIGHEST GROWTH IN THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: TOXICOGENOMICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 23: PHARMACEUTICALS & BIOPHARMACEUTICALS TO COMMAND THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: IN SILICO MODELS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 25: IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT (2018)
  • FIGURE 26: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 27: TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2017)
  • FIGURE 28: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 29: ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 30: KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2017 TO AUGUST 2019
  • FIGURE 31: IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2018
  • FIGURE 32: IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING (2018)
  • FIGURE 33: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 34: MERCK KGAA: COMPANY SNAPSHOT (2018)
  • FIGURE 35: EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2018)
  • FIGURE 36: GE HEALTHCARE: COMPANY SNAPSHOT (2018)
  • FIGURE 37: LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2018)
  • FIGURE 38: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 39: SGS S.A.: COMPANY SNAPSHOT (2018)
  • FIGURE 40: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 41: QIAGEN N.V.: COMPANY SNAPSHOT (2018)
  • FIGURE 42: EVOTEC AG: COMPANY SNAPSHOT (2018)
  • FIGURE 43: CATALENT, INC.: COMPANY SNAPSHOT (2018)
目次
Product Code: BT 2373

"The global in-vitro toxicology testing market is projected to grow at a CAGR of 9.3%."

The in-vitro toxicology testing market is expected to reach USD 12.7 billion by 2024 from an estimated USD 8.1 billion in 2019, at a CAGR of 9.3%. The opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the primary growth factors for this industry. The increasing focus of the pharmaceutical and cosmetics industries on using in-vitro methods for product testing along with the improvement in silico methods for predictive toxicology studies are expected to offer significant growth opportunities for players in this market. However, the dearth of skilled professionals is a substantial market challenge.

"The software segment is expected to grow at the highest rate during the forecast period."

Based on the product & service, the in-vitro toxicology testing market is segmented into consumables, assays, equipment, software, and services. The software segment is projected to witness the highest growth in the in-vitro toxicology testing market during the forecast period. Growth in this segment is driven mostly by the rising number of new technologies to develop in-vitro signatures and computational models capable of predicting in vivo responses. Also, the increasing use of the latest software in the industry and the academia to predict toxicity by comparing the data of new substances with other structurally or biologically similar compounds, are expected to drive the growth of this segment.

"The ADME segment is expected to account for the largest market share in 2018."

Based on toxicity endpoints & tests undertaken across all industries, the in-vitro toxicity testing market is segmented into ADME; skin irritation, corrosion, and sensitization; genotoxicity; cytotoxicity; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endpoints & tests. The ADME segment accounted for the largest share of the in-vitro toxicity testing market in 2018. This can be attributed to the high adoption during the drug development process with the advantage of producing highly reproducible & accurate data.

"Toxicogenomics is expected to grow at the highest rate during the forecast period."

The toxicogenomics segment is expected to grow at the highest CAGR during the forecast period, primarily due to the technological advancements taking place in the field of proteomics and genomics. Also, the improvements in proteomic technologies are enhancing the study of gene & protein activity during toxicity analysis. Technological advancements taking place in the field of proteomics and genomics will further drive the growth of this segment in the coming years.

"Europe is expected to hold the largest share for players operating in the in-vitro toxicology testing market."

Europe accounted for the largest share of the in-vitro toxicology testing market in 2018. Factors such as high adoption of in-vitro toxicology testing assays and services in the cosmetics and chemical industries after the ban on animal testing in the region are among the few factors expected to contribute to the growth of this market.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
  • By Designation: C-level (35%), Director-level (25%), and Others (40%)
  • By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and the Middle East & Africa (2%)

The prominent players in the in-vitro toxicology testing market include: Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).

Research Coverage:

This report analyzes the market for various in-vitro toxicology testing products and their adoption patterns. It aims at estimating the market size and future growth potential of the global in-vitro toxicology testing market and its product & service, technology, toxicity endpoint & test, industry, method, and regional segments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global in-vitro toxicology testing market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global in-vitro toxicology testing market
  • Market Development: Comprehensive information on the lucrative emerging regions
  • Market Diversification: Exhaustive information about the new product, growing geographies, and recent developments in the global in-vitro toxicology testing market
  • Competitive Assessment: In-depth assessment of market ranking, growth strategies, revenue analysis, and services of leading players in the global in-vitro toxicology testing market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 DATA TRIANGULATION APPROACH
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
  • 4.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION (2017-2024)
  • 4.5 IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Opposition to animal testing
      • 5.2.1.2 Technological advancements
      • 5.2.1.3 R&D on early-stage toxicity detection
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 Reluctance of regulatory authorities to consider alternative methods for proving safety and efficacy
      • 5.2.2.2 Failure to establish the intricacies of in vivo conditions
      • 5.2.2.3 Lack of in vitro models to study complex endpoints
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Increasing focus on drug discovery and personalized medicine using in vitro methods
      • 5.2.3.2 Increasing number of toxicology databases
    • 5.2.4 MARKET CHALLENGES
      • 5.2.4.1 Dearth of skilled professionals

6 INDUSTRY INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 INDUSTRY TRENDS
    • 6.2.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
  • 6.3 SUPPLY CHAIN ANALYSIS
  • 6.4 REGULATORY COMMITTEE ACTIVITIES
    • 6.4.1 MAJOR STAKEHOLDERS
    • 6.4.2 KEY INFLUENCERS

7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE

  • 7.1 INTRODUCTION
  • 7.2 CONSUMABLES
    • 7.2.1 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
  • 7.3 ASSAYS
    • 7.3.1 BACTERIAL TOXICITY ASSAYS
      • 7.3.1.1 Bacterial assays dominate the market as they are the most widely adopted assay type across industries
    • 7.3.2 ENZYME TOXICITY ASSAYS
      • 7.3.2.1 Enzyme toxicity assays are increasingly used for endocrine-disrupting studies-a key factor driving market growth
    • 7.3.3 CELL-BASED ELISA & WESTERN BLOTS
      • 7.3.3.1 Cell-based assays are cost-effective, owing to which they are witnessing increasing adoption in drug discovery
    • 7.3.4 RECEPTOR-BINDING ASSAYS
      • 7.3.4.1 Receptor-binding assays are well-suited for high-throughput formats, a key factor driving the adoption of these products
    • 7.3.5 TISSUE CULTURE ASSAYS
      • 7.3.5.1 Tissue culture assays offer the advantage of mimicking in vivo tissue architecture
    • 7.3.6 OTHER ASSAYS
  • 7.4 EQUIPMENT
    • 7.4.1 FULLY AUTOMATED EQUIPMENT IS WITNESSING GROWING ADOPTION IN RESEARCH
  • 7.5 SOFTWARE
    • 7.5.1 SOFTWARE TOOLS ARE VITAL IN REDUCING ANALYSIS TIMES AND MANAGING LARGE AMOUNTS OF DATA GENERATED IN OPERATIONS
  • 7.6 SERVICES
    • 7.6.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS

8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST

  • 8.1 INTRODUCTION
  • 8.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING
    • 8.2.1 ADME TESTING TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
  • 8.3 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING
    • 8.3.1 SKIN IRRITATION, CORROSION, AND SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN THE COSMETICS INDUSTRY
  • 8.4 GENOTOXICITY TESTING
    • 8.4.1 MORE GENOTOXICITY TESTS ARE REVIEWED AND VALIDATED BY REGULATORY AUTHORITIES THAN ANY OTHER ENDPOINT-A KEY DRIVER FOR MARKET GROWTH
  • 8.5 CYTOTOXICITY TESTING
    • 8.5.1 RISING NEED FOR BIOSAFETY IS LARGELY CONTRIBUTING TO THE GROWTH OF THE CYTOTOXICITY TESTING MARKET
  • 8.6 OCULAR TOXICITY TESTING
    • 8.6.1 IN VITRO AND EX VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING
  • 8.7 ORGAN TOXICITY TESTING
    • 8.7.1 HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY
  • 8.8 PHOTOTOXICITY TESTING
    • 8.8.1 VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE THE PHOTOSAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS
  • 8.9 DERMAL TOXICITY TESTING
    • 8.9.1 IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN THE COMING YEARS
  • 8.10 OTHER TOXICITY ENDPOINTS & TESTS

9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY

  • 9.1 INTRODUCTION
  • 9.2 CELL CULTURE TECHNOLOGIES
    • 9.2.1 CELL- & TISSUE-BASED TECHNOLOGIES ARE THE MOST WIDELY ADOPTED IN IN VITRO TESTING
  • 9.3 HIGH-THROUGHPUT TECHNOLOGIES
    • 9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IS DRIVING MARKET GROWTH
  • 9.4 TOXICOGENOMICS
    • 9.4.1 IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ARE ENHANCING THE STUDY OF GENE & PROTEIN ACTIVITY DURING TOXICITY ANALYSIS

10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY

  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICALS & BIOPHARMACEUTICALS
    • 10.2.1 DRUG ATTRITION RATE IS LEADING TO THE HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN THE EARLY STAGES OF DRUG DEVELOPMENT
  • 10.3 COSMETICS & HOUSEHOLD PRODUCTS
    • 10.3.1 BAN ON ANIMAL TESTING IS INCREASING THE ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING
  • 10.4 FOOD
    • 10.4.1 INCREASING FOCUS ON FOOD SAFETY IS DRIVING MARKET GROWTH
  • 10.5 CHEMICALS
    • 10.5.1 INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICAL TESTING IS PROPELLING THE MARKET

11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD

  • 11.1 INTRODUCTION
  • 11.2 CELLULAR ASSAYS
    • 11.2.1 DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS
  • 11.3 BIOCHEMICAL ASSAYS
    • 11.3.1 BIOCHEMICAL ASSAYS FIND WIDER APPLICATION IN THE PHARMACEUTICAL INDUSTRY AS COMPARED TO THE CHEMICAL AND FOOD INDUSTRIES
  • 11.4 IN SILICO MODELS
    • 11.4.1 IN SILICO MODELS ARE EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 11.5 EX VIVO MODELS
    • 11.5.1 EX VIVO MODELS ARE WIDELY USED IN SKIN & EYE TOXICITY TESTING IN THE COSMETIC INDUSTRY

12 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 EUROPE
    • 12.2.1 GERMANY
      • 12.2.1.1 Germany holds the largest share of the European market
    • 12.2.2 UK
      • 12.2.2.1 Rising awareness, growing R&D, and increasing collaborations are key indicators of market growth in the UK
    • 12.2.3 FRANCE
      • 12.2.3.1 Research initiatives supported by the government are aiding market growth in France
    • 12.2.4 ITALY
      • 12.2.4.1 Growth in this market is mainly driven by the increasing life science R&D
    • 12.2.5 SPAIN
      • 12.2.5.1 Spain's growing chemical industry is a major factor supporting the in vitro toxicology testing market in the country
    • 12.2.6 REST OF EUROPE
  • 12.3 NORTH AMERICA
    • 12.3.1 US
      • 12.3.1.1 The US dominates the North American in vitro toxicology testing market due to a growing focus on biomarker discovery and research in the field of structure-based drug design
    • 12.3.2 CANADA
      • 12.3.2.1 Strong support for R&D and focus on developing new therapies will support market growth in Canada
  • 12.4 ASIA PACIFIC
    • 12.4.1 CHINA
      • 12.4.1.1 Increasing international pressure to ban animal testing methods will propel market growth in the coming years
    • 12.4.2 JAPAN
      • 12.4.2.1 Use of artificial skin patches and plates of cultured human cells has increased in Japan
    • 12.4.3 INDIA
      • 12.4.3.1 Growing CRAMs industry and the ban on the use of animals in cosmetics and universities are likely to propel market growth
    • 12.4.4 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 LOW COST OF DRUG TRIALS HAVE MADE LATIN AMERICA A POPULAR OUTSOURCING MARKET
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 INCREASING R&D INVESTMENTS AND FOCUS ON THE DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 MARKET SHARE ANALYSIS
  • 13.3 COMPETITIVE LEADERSHIP MAPPING
    • 13.3.1 VISIONARY LEADERS
    • 13.3.2 INNOVATORS
    • 13.3.3 DYNAMIC DIFFERENTIATORS
    • 13.3.4 EMERGING COMPANIES
  • 13.4 COMPETITIVE SITUATION AND TRENDS
    • 13.4.1 PRODUCT & SERVICE LAUNCHES
    • 13.4.2 EXPANSIONS
    • 13.4.3 ACQUISITIONS
    • 13.4.4 OTHER STRATEGIES

14 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 14.1 THERMO FISHER SCIENTIFIC, INC.
  • 14.2 MERCK KGAA
  • 14.3 EUROFINS SCIENTIFIC SE
  • 14.4 GE HEALTHCARE
  • 14.5 COVANCE, INC.
  • 14.6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 14.7 SGS S.A.
  • 14.8 BIO-RAD LABORATORIES, INC.
  • 14.9 QIAGEN N.V.
  • 14.10 CYPROTEX PLC
  • 14.11 PROMEGA CORPORATION
  • 14.12 CATALENT, INC.
  • 14.13 GENTRONIX LIMITED
  • 14.14 MB RESEARCH LABORATORIES
  • 14.15 BIOIVT
  • 14.16 CREATIVE BIOLABS
  • 14.17 GVK BIOSCIENCES PRIVATE LIMITED
  • 14.18 SHANGHAI MEDICILON INC.
  • 14.19 CREATIVE BIOARRAY
  • 14.20 INSPHERO

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15 APPENDIX

  • 15.1 INSIGHTS OF INDUSTRY EXPERTS
  • 15.2 DISCUSSION GUIDE
  • 15.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.4 AVAILABLE CUSTOMIZATIONS
  • 15.5 RELATED REPORTS
  • 15.6 AUTHOR DETAILS